首页> 美国卫生研究院文献>BMC Public Health >Maternal bodies and medicines: a commentary on risk and decision-making of pregnant and breastfeeding women and health professionals
【2h】

Maternal bodies and medicines: a commentary on risk and decision-making of pregnant and breastfeeding women and health professionals

机译:孕产妇和药品:关于孕妇和哺乳期妇女以及卫生专业人员的风险和决策的评论

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe perceived risk/benefit balance of prescribed and over-the-counter (OTC) medicine, as well as complementary therapies, will significantly impact on an individual’s decision-making to use medicine. For women who are pregnant or breastfeeding, this weighing of risks and benefits becomes immensely more complex because they are considering the effect on two bodies rather than one. Indeed the balance may lie in opposite directions for the mother and baby/fetus. The aim of this paper is to generate a discussion that focuses on the complexity around risk, responsibility and decision-making of medicine use by pregnant and breastfeeding women. We will also consider the competing discourses that pregnant and breastfeeding women encounter when making decisions about medicine.
机译:背景技术处方药和非处方药(OTC)以及补充疗法对风险/收益的感知平衡将严重影响个人使用药物的决策。对于怀孕或母乳喂养的妇女,风险和收益的权衡变得更加复杂,因为他们正在考虑对两个身体而不是一个身体的影响。实际上,母亲和婴儿/胎儿的平衡可能处于相反的方向。本文的目的是引起讨论,重点讨论孕妇和哺乳期妇女在用药的风险,责任和决策方面的复杂性。我们还将考虑孕妇和哺乳期妇女在做出药物决定时会遇到的竞争性话题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号